|Project Title||Actemra (Tocilizumab) Utilization Among Pregnant Women|
FDA required a pregnancy registry for Actemra (tocilizumab) when it was approved for RA. The sponsor is citing recruitment challenges given the limited use of Actemra in pregnant women.
Tuesday, July 18, 2017
Modular Programs and Summary Tables